Skip to main content
. 2017 Feb 24;12(2):e0172795. doi: 10.1371/journal.pone.0172795

Fig 6. Treatment with anti-IL-4 mAb upregulates Foxp3 expression on MLN OVA-specific CD4+ T cells of EW-fed R23-3 mice.

Fig 6

A, Protocol for anti-IL-4 mAb (αIL-4) or control antibody (RatIgG) injection (↓) and EW diet. B, Percentages of OVA-specific Foxp3+ CD4+ T cells among total OVA-specific CD4+ T cells from the spleen and MLNs of mice treated with control antibody (RatIgG) or αIL-4, C, Weight change (relative to day 0 [100%]). D, H&E staining of the jejunum (n = 3 per group). These data are representative of two independent experiments.